ORASURE TECHNOLOGIES INC. - COMMON STOCK

OraSure Technologies Reports 2Q21 Revenue of $57.6 Million Driven by Strong Rebound in Core Business

03 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. to Hold 2021 Second Quarter Earnings Conference Call Tuesday, August 3, 2021, 5:00 p.m. ET

27 Jul 2021 16:01:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the Raymond James 2021 Human Health and Innovation Conference

17 Jun 2021 16:05:00 By Nasdaq GlobeNewswire

OraSure and the Will Rodgers Liver Health Foundation to Heighten Awareness Around the Importance of Hepatitis C Testing

14 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Technologies Receives Three Emergency Use Authorizations for its COVID-19 Rapid Antigen Tests for Non-Prescription (OTC), Professional and Prescription Use

07 Jun 2021 09:18:15 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the Jefferies Virtual Healthcare Conference

28 May 2021 07:00:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the UBS Global Healthcare Virtual Conference

18 May 2021 07:00:00 By Nasdaq GlobeNewswire

OraSure Technologies Appoints Scott Gleason As Senior Vice President Investor Relations and Corporate Communications

17 May 2021 07:00:01 By Nasdaq GlobeNewswire

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 18, 2021

12 May 2021 06:00:00 By Nasdaq GlobeNewswire

Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV

10 May 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. Announces First Quarter 2021 Financial Results and Provides COVID-19 Update

05 May 2021 16:00:00 By Nasdaq GlobeNewswire

OraSure Technologies to Hold 2021 First Quarter Earnings Conference Call Wednesday, May 5, 2021, 5:00 p.m. ET

30 Apr 2021 16:01:00 By Nasdaq GlobeNewswire

OraSure Technologies Submits COVID-19 Rapid Antigen Prescription Home Self-Test and Professional Test to FDA for Emergency Use Authorization

30 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

OraSure Technologies, Inc. Announces 2020 Full-Year and Fourth Quarter Financial Results and Provides COVID-19 Update

01 Mar 2021 16:15:00 By Nasdaq GlobeNewswire

OraSure Technologies to Present at the Raymond James 42nd Annual Institutional Investors Conference

24 Feb 2021 16:01:00 By Nasdaq GlobeNewswire

2020 Fourth Quarter Earnings Conference Call Monday, March 1, 2021, 5:00 p.m. ET

18 Feb 2021 06:00:01 By Nasdaq GlobeNewswire

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Included in EUA Granted to Ambry Genetics for Use in COVID-19 RT-PCR Saliva Test

29 Jan 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure Subsidiary DNA Genotek’s OMNIgene®·ORAL Saliva Collection Device Receives Health Canada Authorization for use in COVID-19 Testing

28 Jan 2021 06:00:00 By Nasdaq GlobeNewswire

OraSure’s OMNIgene®·ORAL Saliva Collection Kit Selected by Chronomics for Use in UK Government “Test to Release for International Travel” COVID-19 Testing Program

26 Jan 2021 07:57:10 By Nasdaq GlobeNewswire

OraSure’s Oragene®•Dx Saliva Collection Kit Included in Industry’s First FDA Authorization for a Whole Exome Sequencing Platform

21 Jan 2021 06:00:00 By Nasdaq GlobeNewswire